The findings were notable: among participants without type 2 diabetes , those receiving the highest dose (12 mg) achieved a mean body weight reduction of approximately 24% over 48 weeks
Given the immense potential benefit to G6PD-deficient patients if new and safe treatment options arise, rigorous clinical studies must be performed to determine the safest choice of drugs for these patients
Reaction: What Should You Do Next
There is also evidence to suggest that nutritional imbalances, food intolerances, a disrupted gut microbiome and sleep issues can contribute to ADHD and treating ADHD through diet and lifestyle modifications can go a long way to easing symptoms
For lower weight individuals, could there eventually be GLP-1 class drugs that do not cause weight loss
Step 4: Ongoing Treatment and Support After beginning treatment, you maintain access to ongoing provider support as needed through the patient portal